{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:01:22Z","timestamp":1753891282764,"version":"3.41.2"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Brachytherapy based on iodine-125 (I-125) is becoming one of the alternative treatment option for advanced non-small cell lung cancer (NSCLC). Chinese herbal medicine (CHM) combined with radiotherapy reduces the complications. In the current study, we attempted to assess the outcomes of treating strategies using CHM, chemotherapy or I-125. 182 patients who underwent I-125 seed implantation alone or in combination with chemotherapy or CHM treatment were enrolled in the current study. The clinical information of the patients were collected, and analyzed after a 5-year follow-up. The overall survival rates at 1, 2, 3, and 5 years were 81, 47, 28, and 20%, respectively, with a median survival time of 24.28 months. For patients receiving chemotherapy combined with I-125 seed brachytherapy, the survival rates were 89, 53, 35, and 29%, respectively. In contrast, those treated with CHM combined with I-125 seed brachytherapy had survival rates of 90, 63, 42, and 23%. Meanwhile, the survival rates for patients treated with <jats:sup>125<\/jats:sup>I seed brachytherapy alone were 69, 32, 12, and 11%. Additionally, patients receiving CHM combined with I-125 seed brachytherapy treatment also showed less complications such as cough and vomit. CHM treatment demonstrated comparable efficacy and less complications to chemotherapy in managing advanced NSCLC under the treatment of I-125.<\/jats:p>","DOI":"10.3389\/fmed.2025.1595640","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T04:10:58Z","timestamp":1750824658000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Chinese herbal medicine improves the treating outcomes in advanced non-small cell lung cancer patients treated with iodine-125 seed brachytherapy: a 5-year follow-up study"],"prefix":"10.3389","volume":"12","author":[{"given":"Linjun","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruiqin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoqing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingchen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023.","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin."},{"key":"B2","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.brachy.2017.11.015","article-title":"Efficacy and safety of iodine-125 radioactive seeds brachytherapy for advanced non-small cell lung cancer-A meta-analysis.","volume":"17","author":"Zhang","year":"2018","journal-title":"Brachytherapy."},{"key":"B3","doi-asserted-by":"publisher","first-page":"403","DOI":"10.5114\/jcb.2022.118117","article-title":"Iodine-125 seeds insertion with trans-arterial chemical infusion for advanced lung cancer: A meta-analysis.","volume":"14","author":"Hong","year":"2022","journal-title":"J Contemp Brachyther."},{"key":"B4","first-page":"49","article-title":"Preliminary observations on lung cancer therapy by interstitial irradiation with iodine 125.","volume":"13","author":"Coloni","year":"1983","journal-title":"Ital J Surg Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13019-022-01820-y","article-title":"I-125 seeds with chemotherapy for progressive non-small-cell lung cancer after first-line treatment: A meta-analysis.","volume":"17","author":"Chen","year":"2022","journal-title":"J Cardiothorac Surg."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.3389\/fphar.2018.01233","article-title":"Maintenance chemotherapy with chinese herb medicine formulas vs. with placebo in patients with advanced non-small cell lung cancer after first-line chemotherapy: A multicenter, randomized, double-blind trial.","volume":"9","author":"Wang","year":"2018","journal-title":"Front Pharmacol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.21037\/tcr.2020.03.64","article-title":"Drug-eluting beads-transcatheter arterial chemoembolization with or without iodine-125 treatment is effective and tolerable in treating advanced non-small cell lung cancer patients: A pilot study.","volume":"9","author":"Zhao","year":"2020","journal-title":"Transl Cancer Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.5114\/jcb.2023.125582","article-title":"Iodine-125 seed brachytherapy combined with pembrolizumab for advanced non-small-cell lung cancer after failure of first-line chemotherapy: A report of two cases and literature review.","volume":"15","author":"Yuan","year":"2023","journal-title":"J Contemp Brachyther."},{"key":"B9","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/HP.0000000000001714","article-title":"Effect of I-125 Seed Implantation on Lung Cancer and Its Environmental Impact.","volume":"125","author":"Lin","year":"2023","journal-title":"Health Phys"},{"key":"B10","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.canrad.2023.01.008","article-title":"Clinical outcomes of intra-arterial chemotherapy combined with iodine-125 seed brachytherapy in the treatment of malignant superior vena cava syndrome caused by small cell lung cancer.","volume":"27","author":"Wang","year":"2023","journal-title":"Cancer Radiother."},{"key":"B11","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.chmed.2023.05.004","article-title":"Traditional Chinese medicines for non-small cell lung cancer: Therapies and mechanisms.","volume":"15","author":"Kong","year":"2023","journal-title":"Chin Herb Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1097\/cm9.0000000000001141","article-title":"Clinical application and mechanism of traditional Chinese medicine in treatment of lung cancer.","volume":"133","author":"Su","year":"2020","journal-title":"Chin Med J."},{"key":"B13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12943-025-02245-6","article-title":"Traditional Chinese medicine in lung cancer treatment.","volume":"24","author":"Xi","year":"2025","journal-title":"Mol Cancer."},{"key":"B14","first-page":"2094","article-title":"Network pharmacology-guided mechanism study uncovers inhibitory effect of Mahuang decoction on lung cancer growth by impeding Akt\/ERK signaling pathways.","volume":"13","author":"Pan","year":"2021","journal-title":"Am J Transl Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.brachy.2020.11.009","article-title":"Brachytherapy for lung cancer.","volume":"20","author":"Qiu","year":"2021","journal-title":"Brachytherapy."},{"key":"B16","doi-asserted-by":"publisher","first-page":"Cd004284","DOI":"10.1002\/14651858.CD004284.pub3","article-title":"Palliative endobronchial brachytherapy for non-small cell lung cancer.","volume":"12","author":"Reveiz","year":"2012","journal-title":"Cochrane Database Syst Rev."},{"key":"B17","doi-asserted-by":"publisher","first-page":"527","DOI":"10.5114\/jcb.2017.72605","article-title":"Implantation of computed tomography-guided Iodine-125 seeds in combination with chemotherapy for the treatment of stage III non-small cell lung cancer.","volume":"9","author":"Huo","year":"2017","journal-title":"J Contemp Brachyther."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1176083","DOI":"10.3389\/fcell.2023.1176083","article-title":"I-125 seeds brachytherapy combined with immunotherapy for MET amplification in non-small cell lung cancer from clinical application to related lncRNA mechanism explore: A case report.","volume":"11","author":"Yang","year":"2023","journal-title":"Front Cell Dev Biol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"111381","DOI":"10.1016\/j.biopha.2021.111381","article-title":"Traditional Chinese medicine and lung cancer\u2013From theory to practice.","volume":"137","author":"Li","year":"2021","journal-title":"Biomed Pharmacother."},{"key":"B20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ctim.2018.07.003","article-title":"Conventional treatment integrated with Chinese herbal medicine improves the survival rate of patients with advanced non-small cell lung cancer.","volume":"40","author":"Wang","year":"2018","journal-title":"Complement Ther Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1007\/s11655-020-3428-5","article-title":"Multidisciplinary and comprehensive Chinese medicine for advanced non-small cell lung cancer patients: A retrospective study of 855 cases.","volume":"27","author":"Huang","year":"2021","journal-title":"Chin J Integr Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1047700","DOI":"10.3389\/fcvm.2022.1047700","article-title":"Role and molecular mechanism of traditional Chinese medicine in preventing cardiotoxicity associated with chemoradiotherapy.","volume":"9","author":"Lv","year":"2022","journal-title":"Front Cardiovasc Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ctim.2015.12.006","article-title":"Traditional Chinese medicine treatment as maintenance therapy in advanced non-small-cell lung cancer: A randomized controlled trial.","volume":"24","author":"Jiang","year":"2016","journal-title":"Complement Ther Med."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1595640\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T04:10:59Z","timestamp":1750824659000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1595640\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,25]]},"references-count":23,"alternative-id":["10.3389\/fmed.2025.1595640"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1595640","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2025,6,25]]},"article-number":"1595640"}}